The CycLex AKT/PKB kinase Assay/Inhibitor Screening Kit is designed to measure the activities of purified AKTs for the rapid and sensitive evaluation of inhibitors or activators It can be used for 96 assays.
| Product Specifications | |
| Application | ELISA |
| Citations for CycLex® AKT/PKB Kinase Assay/Inhibitor Screening Kit – 3 Found |
| Mure, Hideo; Matsuzaki, Kazuhito; Kitazato, Keiko T; Mizobuchi, Yoshifumi; Kuwayama, Kazuyuki; Kageji, Teruyoshi; Nagahiro, Shinji. Akt2 and Akt3 play a pivotal role in malignant gliomas. Neuro-Oncology. 2010;12(3):221-32. PubMed |
| Bresin, Antonella; Ragone, Gianluca; Cristofoletti, Cristina; Arcelli, Diego; Bassi, Cristian; Caprini, Elisabetta; Fiorenza, Maria Teresa; Helmer Citterich, Mauro; Russo, Giandomenico; Narducci, Maria Grazia. T Cell Leukemia/Lymphoma 1A is essential for mouse epidermal keratinocytes proliferation promoted by insulin-like growth factor 1. Plos One. 13(10):e0204775. PubMed |
| Uko, Nne E; Güner, Osman F; Bowen, J Phillip; Matesic, Diane F. Akt Pathway Inhibition of the Solenopsin Analog, 2-Dodecylsulfanyl-1,-4,-5,-6-tetrahydropyrimidine. Anticancer Research. 2019;39(10):5329-5338. PubMed |